Cargando…

Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity

GM-CSF signaling regulates hematopoiesis and immune responses. CSF2RA, the gene encoding the α subunit for GM-CSF, is significantly downregulated in t(8;21) (RUNX1-ETO or RE) leukemia patients, suggesting that it may serve as a tumor suppressor. We previously reported that GM-CSF signaling is inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Stephanie, Matsuura, Shinobu, Mowery, Cody T., Stoner, Samuel A., Lam, Kentson, Ran, Dan, Davis, Amanda G., Lo, Miao-Chia, Zhang, Dong-Er
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214981/ https://www.ncbi.nlm.nih.gov/pubmed/27389055 http://dx.doi.org/10.1038/leu.2016.167

Ejemplares similares

Interference with RUNX1/ETO Leukemogenic Function by Cell-Penetrating Peptides Targeting the NHR2 Oligomerization Domain
por: Bartel, Yvonne, et al.
Publicado: (2013)

Cooperation between RUNX1-ETO9a and Novel Transcriptional Partner KLF6 in Upregulation of Alox5 in Acute Myeloid Leukemia
por: DeKelver, Russell C., et al.
Publicado: (2013)

MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO
por: Kohrs, Nicole, et al.
Publicado: (2016)

The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling
por: Stoner, Samuel A., et al.
Publicado: (2020)

RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
por: van der Kouwe, Emiel, et al.
Publicado: (2019)

RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner
por: Abdallah, Mohamed Gaber, et al.
Publicado: (2021)

The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype
por: Forster, V J, et al.
Publicado: (2016)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
por: Loke, Justin, et al.
Publicado: (2017)

Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancer
por: Bowers, Sarion R., et al.
Publicado: (2010)

RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
por: Ponnusamy, K, et al.
Publicado: (2015)

RUNX1 and its fusion oncoprotein derivative RUNX1-ETO induce senescence-like growth arrest independently of replicative stress
por: Wolyniec, Kamil, et al.
Publicado: (2009)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21)
por: Lu, Lianghao, et al.
Publicado: (2018)

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
por: Martinez-Soria, Natalia, et al.
Publicado: (2018)

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
por: Martinez-Soria, Natalia, et al.
Publicado: (2019)

The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG
por: Kugler, Eitan, et al.
Publicado: (2023)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
por: Mukherjee, Bratati, et al.
Publicado: (2022)

Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells
por: Nafria, Monica, et al.
Publicado: (2020)

Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects
por: Gopalswamy, Mohanraj, et al.
Publicado: (2022)

Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia
por: Issa, Hasan, et al.
Publicado: (2023)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023)

Epidemiological studies of the leukemogenic effects of radiation.
por: Lilienfeld, A. M.
Publicado: (1966)

The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)

Development of Dendritic Cells from GM-CSF(-/-) Mice in vitro : GM-CSF Enhances Production and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)

ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2
por: Ghosh, Hiyaa S., et al.
Publicado: (2014)

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia
por: Dou, Liping, et al.
Publicado: (2019)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
por: Shiomi, Aoi, et al.
Publicado: (2015)

A Review of GM-CSF Therapy in Sepsis
por: Mathias, Brittany, et al.
Publicado: (2015)

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

GM-CSF: Orchestrating the Pulmonary Response to Infection
por: McCormick, Thomas S., et al.
Publicado: (2022)

Role of GM-CSF in lung balance and disease
por: Chen, Yingzi, et al.
Publicado: (2023)

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
por: Ptasinska, A, et al.
Publicado: (2012)

Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase
por: Schoenherr, Caroline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ck07mli1g5vi0fom6c27ngm6r4